Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Bostel, T.; Dreher, C.; Wollschlaeger, D. et al.
The Prediction of the pathological Response in Rectal Carcinoma on the Basis of daily MRT Imaging during neoadjuvant RadiochemotherapySTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. SUPPL 1. 2020 S. S11-S11
Heckel, Maria; Vogt, Annika R.; Stiel, Stephanie et al.
The quality of care of the dying in hospital-next-of-kin perspectivesSUPPORTIVE CARE IN CANCER. 2020
Heckel, Maria; Vogt, Annika R.; Stiel, Stephanie et al.
The quality of care of the dying in hospital-next-of-kin perspectives (vol 28, pg 4527, 2020)SUPPORTIVE CARE IN CANCER. Bd. 28. H. 9. 2020 S. 4539-4539
Gkika, E.; Schimek-Jasch, T.; Kremp, S. et al.
The Role of Different Chemotherapy Protocols for Concurrent CRT in Locally Advanced NSCLCINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. Bd. 108. H. 3. 2020 S. E102-E103
Gkika, E.; Schimek-Jasch, T.; Kremp, S. et al.
The Role of different Chemotherapy Protocols for simultaneous Radiochemotherapy in locally advanced NSCLC - A secondary Analysis of the PET Plan StudySTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. SUPPL 1. 2020 S. S84-S84
Bostel, Tilman; Ruehle, Alexander; Rackwitz, Tilmann et al.
The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors-A Multicenter Analysis of a Rare EventCANCERS. Bd. 12. H. 7. 2020
Ditsch, N; Schmidt, M
Therapie des fortgeschrittenen hormonrezeptor(HR)-positiven HER2-negativen MammakarzinomsSenologie. Bd. 17. 2020 S. 23-30
Theobald, M
Therapieoptionen beim Multiplen MyelomTumorDiagnostik und Therapie. Bd. 41. 2020 S. 231-4
Xu, Rui-hua; Arkenau, Hendrik-Tobias; Bang, Yung-Jue et al.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line therapy in patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinomaJOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Herbert, S. L.; Woeckel, A.; Kreienberg, R. et al.
To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?BREAST CANCER RESEARCH AND TREATMENT. 2020